n-caproylglycine has been researched along with Autism Spectrum Disorder in 1 studies
*Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, Y; Tanuma, N; Yamada, H; Yui, K | 1 |
1 other study(ies) available for n-caproylglycine and Autism Spectrum Disorder
| Article | Year |
|---|---|
Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adolescent; Antioxidants; Autism Spectrum Disorder; Biomarkers; Child; Child, Preschool; Deoxyguanosine; Enzyme Activation; Female; Glycine; Humans; Male; Reproducibility of Results; Sensitivity and Specificity; Superoxide Dismutase; Young Adult | 2017 |